156 related articles for article (PubMed ID: 10935513)
1. Imaging prostate cancer invasion with multi-nuclear magnetic resonance methods: the Metabolic Boyden Chamber.
Pilatus U; Ackerstaff E; Artemov D; Mori N; Gillies RJ; Bhujwalla ZM
Neoplasia; 2000; 2(3):273-9. PubMed ID: 10935513
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of prostate cancer cell invasion studied in vitro by NMR microscopy.
Artemov D; Pilatus U; Chu S; Mori N; Nelson JB; Bhujwalla ZM
Magn Reson Med; 1999 Aug; 42(2):277-82. PubMed ID: 10440952
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic endothelial cells actively regulate prostate cancer cell invasion.
Shah T; Wildes F; Kakkad S; Artemov D; Bhujwalla ZM
NMR Biomed; 2016 Jul; 29(7):904-11. PubMed ID: 27149683
[TBL] [Abstract][Full Text] [Related]
5. Spherical Invasion Assay: A Novel Method to Measure Invasion of Cancer Cells.
Richbart SD; Merritt JC; Moles EG; Brown KC; Adeluola AA; Finch PT; Hess JA; Tirona MT; Miles SL; Valentovic MA; Dasgupta AP
Bio Protoc; 2022 Feb; 12(4):e4320. PubMed ID: 35340295
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the invasive potential of human gynecological tumor cell lines with the in vitro Boyden chamber assay: influences of the ability of cells to migrate through the filter membrane.
Sieuwerts AM; Klijn JG; Foekens JA
Clin Exp Metastasis; 1997 Jan; 15(1):53-62. PubMed ID: 9009106
[TBL] [Abstract][Full Text] [Related]
7. [Screening of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) by cDNA microarray and influence of overexpression of PAG1 on biologic behavior of human metastatic prostatic cancer cell line in vitro].
Yu WJ; Wang YW; Xie ZG; You JF; Wang JL; Cui XL; Pei F; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):88-94. PubMed ID: 20388373
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
[TBL] [Abstract][Full Text] [Related]
9. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
10. SKI-606 (Bosutinib) blocks prostate cancer invasion, growth, and metastasis in vitro and in vivo through regulation of genes involved in cancer growth and skeletal metastasis.
Rabbani SA; Valentino ML; Arakelian A; Ali S; Boschelli F
Mol Cancer Ther; 2010 May; 9(5):1147-57. PubMed ID: 20423991
[TBL] [Abstract][Full Text] [Related]
11. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
13. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynold LM
Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia and the presence of human vascular endothelial cells affect prostate cancer cell invasion and metabolism.
Ackerstaff E; Artemov D; Gillies RJ; Bhujwalla ZM
Neoplasia; 2007 Dec; 9(12):1138-51. PubMed ID: 18084621
[TBL] [Abstract][Full Text] [Related]
15. [SHP2 and MKP5 in P2Y purinergic receptor-mediated prostate cancer invasion].
He HY; Zheng J; Li Y; Heng WJ; Fang WG
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):288-92. PubMed ID: 16181551
[TBL] [Abstract][Full Text] [Related]
16. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
17. Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines.
Hoosein NM; Boyd DD; Hollas WJ; Mazar A; Henkin J; Chung LW
Cancer Commun; 1991 Aug; 3(8):255-64. PubMed ID: 1653586
[TBL] [Abstract][Full Text] [Related]
18. Prostate stromal cell-derived hepatocyte growth factor induces invasion of prostate cancer cell line DU145 through tumor-stromal interaction.
Nishimura K; Kitamura M; Miura H; Nonomura N; Takada S; Takahara S; Matsumoto K; Nakamura T; Matsumiya K
Prostate; 1999 Nov; 41(3):145-53. PubMed ID: 10517872
[TBL] [Abstract][Full Text] [Related]
19. Urokinase plasminogen activator is necessary but not sufficient for prostate cancer cell invasion.
Jarrard DF; Hansen NM; Patai B; Rukstalis DB
Invasion Metastasis; 1995; 15(1-2):34-45. PubMed ID: 7672930
[TBL] [Abstract][Full Text] [Related]
20. Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasion.
Jarrard DF; Blitz BF; Smith RC; Patai BL; Rukstalis DB
Prostate; 1994; 24(1):46-53. PubMed ID: 8290389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
